Younis Islam R - Department of Clinical Pharmacology, Gilead Sciences Inc

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 75 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers

Mariam A Ahmed,Rajesh Krishna, Noha Rayad,Salwa Albusaysi,Amitava Mitra, Elizabeth Shang,Yuen Yi Hon,Bilal AbuAsal,Rana Bakhaidar,Youssef M Roman,Indranil Bhattacharya,James Cloyd,Munjal Patel,Reena V Kartha,Islam R Younis

Clinical pharmacology and therapeuticsno. 6 (2024): 1412-1432

引用0浏览0WOS引用

Pharmacokinetics and Safety of Cilofexor and Firsocostat in Healthy Japanese and Non-Japanese Participants

Islam R. Younis,Cara Nelson,Elijah J. Weber,Gong Shen,Ann R. Qin,Deqing Xiao,Timothy R. Watkins,Ahmed A. Othman

JOURNAL OF CLINICAL PHARMACOLOGY (2024)

引用0浏览0WOS引用

New Horizons of Model Informed Drug Development in Rare Diseases Drug Development

Amitava Mitra, Nessy Tania,Mariam A. Ahmed, Noha Rayad,Rajesh Krishna,Salwa Albusaysi,Rana Bakhaidar, Elizabeth Shang,Maria Burian,Michelle Martin-Pozo,Islam R. Younis

Clinical pharmacology and therapeuticsno. 6 (2024): 1398-1411

引用0浏览0WOS引用

Evaluation of the Potential for Cytochrome P450 and Transporter-Mediated Drug–Drug Interactions for Firsocostat, a Liver-Targeted Inhibitor of Acetyl-CoA Carboxylase

Elijah J. Weber,Islam R. Younis,Cara Nelson,Ann R. Qin,Timothy R. Watkins,Ahmed A. Othman

Clinical Pharmacokineticspp.1-12, (2024)

引用0浏览0WOS引用

Evaluation of the Effects of Meal Type and Acid-Reducing Agents on the Pharmacokinetics of Cilofexor, a Selective Nonsteroidal Farnesoid X Receptor Agonist

Elijah J. Weber,Islam R. Younis,Lulu Wang,Deqing Xiao,William T. Barchuk,Ahmed A. Othman

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENTno. 6 (2024): 677-687

引用0浏览0WOS引用

Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial

Michelle S. S. Cespedes,Moupali Das,Jenna Yager,Maria Prins,Ivanka Krznaric, Jan de Jong,Deqing Xiao,Yongwu Shao,Pamela Wong,Alexander Kintu,Christoph Carter,Elske Hoornenborg,Peter Ruane,John Phoenix,Islam Younis,Jason Halperin

TRANSGENDER HEALTHno. 1 (2024): 46-52

引用3浏览0WOS引用

Feasibility of Using Population Pharmacokinetics-Based Virtual Control Groups in Organ Impairment Studies

Islam R. Younis,Fan Wang,Ahmed A. Othman

JOURNAL OF CLINICAL PHARMACOLOGYno. 6 (2024): 713-718

引用0浏览0WOS引用

Pharmacokinetics and Safety of Firsocostat, an Acetyl-Coenzyme A Carboxylase Inhibitor, in Participants with Mild, Moderate, and Severe Hepatic Impairment

Islam R. Younis,Cara Nelson,Elijah J. Weber,Ann R. Qin,Timothy R. Watkins, Ahmed A. Othman

JOURNAL OF CLINICAL PHARMACOLOGYno. 7 (2024): 878-886

引用0浏览0WOS引用

Pharmacokinetics, pharmacodynamics, safety and tolerability of cilofexor, a novel nonsteroidal Farnesoid X receptor agonist, in healthy volunteers

Islam R. R. Younis, Brian J. J. Kirby,Andrew N. N. Billin,Deqing Xiao,Qinghua Song,Timothy R. R. Watkins,Ahmed A. A. Othman

Clin Transl Sci（2023）

引用8浏览0WOS引用

Model-Informed Approaches and Innovative Clinical Trial Design for Adeno-Associated Viral Vector-based Gene Therapy Product Development - A White Paper

Amitava Mitra,Mariam A Ahmed,Rajesh Krishna,Kefeng Sun,Francis D Gibbons,Olivia Campagne, Noha Rayad,Youssef M Roman,Salwa Albusaysi,Maria Burian,Islam Younis

Clinical pharmacology and therapeuticsno. 3 (2023): 515-529

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn